Cerebellar pathology and disability worsening in relapsing‐remitting multiple sclerosis: A retrospective analysis from the CombiRx trial

Maria Petracca (1, 2) , Gary Cutter (3) , Sirio Cocozza (1, 4) , Leorah Freeman (5) , John Kangarlu (1) , Monica Margoni (1, 5) , Matteo Moro (1, 6) , Stephen Krieger (1) , Mohamed Mounir El Mendili (7, 8) , Amgad Droby (1, 9, 10, 10) , Jerry Wolinsky (11) , Fred Lublin (1) , Matilde Inglese (1, 12, 13)

1 MSSM - Icahn School of Medicine at Mount Sinai [New York]
2 UNIROMA - Università degli Studi di Roma "La Sapienza" = Sapienza University [Rome]
3 Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama, USA
4 University of Naples Federico II = Università degli studi di Napoli Federico II
5 University of Texas at Austin [Austin]
6 DIBRIS - Dipartimento di Informatica, Bioingegneria, Robotica e Ingegneria dei Sistemi [Genova]
7 CRMBM - Centre de résonance magnétique biologique et médicale
8 CEMEREM - Centre d'Exploration Métabolique par Résonance Magnétique [Hôpital de la Timone - APHM]
9 Laboratory for Early Markers of Neurodegeneration (LEMON), Neurological Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
10 TAU - Tel Aviv University
11 University of Texas Health Science Center at Houston (UTHealth), Houston, Texas, USA
12 UniGe - Università degli studi di Genova = University of Genoa
13 Ospedale Policlinico San Martino, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Genoa, Italy

Domaines: Imagerie

Maria Petracca, Gary Cutter, Sirio Cocozza, Leorah Freeman, John Kangarlu, et al.. Cerebellar pathology and disability worsening in relapsing‐remitting multiple sclerosis: A retrospective analysis from the CombiRx trial. European Journal of Neurology, 2022, 29 (2), pp.515-521. ⟨10.1111/ene.15157⟩. ⟨hal-03534084⟩